Solvay S.A.
Participation notification by Blackrock Inc.
Brussels, 8 March 2021, 08:30 CET - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notification indicating that it crossed the threshold of 3%.
| Date on which the threshold was crossed | Voting rights after the transaction | Equivalent financial instruments after the transaction | Total |
| March 2, 2021 | 2.90% | 0.18% | 3.08% |
The latest notification, dated March 3, 2021, contains the following information:
- Reason for the notification: acquisition or disposal of voting securities or voting rights
- Notified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)
- Date on which the threshold is crossed: March 2, 2021
- Threshold of direct voting rights crossed: 3% downwards
- Denominator: 105,876,416
- Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going below 3%.
Transparency notifications and the full chain of controlled undertakings through which the holding is effectively held is available on the Investor Relations Section of Solvay's website.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S6.11.2025 19:00:56 CET | Press release
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
BONDUELLE6.11.2025 18:00:00 CET | Press release
BONDUELLE - Quarter 1 FY 2025-2026 Sales: The Bonduelle Group confirms its resilience in a demanding environment
Verkkokauppa.com Oyj6.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Vivoryon Therapeutics N.V.6.11.2025 17:31:00 CET | Press release
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
Aspo Plc6.11.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 6.11.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
